Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Intellect Neurosciences, Inc.v386765_ex99-1.htm

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 13, 2014

 

Intellect Neurosciences, Inc.

(Exact Name Of Registrant As Specified In Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

333-128226   20-8329066
(Commission File Number)   (I.R.S. Employer Identification No.)

 

550 Sylvan Ave., Suite 101

Englewood Cliffs, New Jersey

  07632
(Address of Principal Executive Offices)   (Zip Code)

 

(201) 608-5101

(Registrant’s Telephone Number, Including Area Code)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

£Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

£Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

£Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

£Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

Item 8.01. Other Events.

 

On August 13, 2014, Intellect Neurosciences, Inc. (OTCBB: ILNS) issued a press release containing a Letter to Shareholders from Elliot Maza, Chairman and CEO regarding the status of OX1. The Press Release is attached hereto as Exhibit 99.1

 

The following exhibit is furnished as part of this Report on Form 8-K:

 

Exhibit Description
   
99.1 Press release dated August 13, 2014.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 14, 2014 INTELLECT NEUROSCIENCES, INC.  
       
  By: /s/ Elliot Maza  
  Name: Elliot Maza  
  Title: Chief Executive Officer